(Q43666932)

English

Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Spina M

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Vaccher E

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Juzbasic S

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Milan I

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nasti G

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Talamini R

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Fasan M

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Antinori A

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nigra E

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tirelli U

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

200-206

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C200%3A%3AAID-CNCR1310%3E3.0.CO%3B2-A

21 January 2018

Identifiers

10.1002/1097-0142(20010701)92:1<200::AID-CNCR1310>3.0.CO;2-A

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43666932&oldid=2102394690"